Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study

Area of Science:

• Oncology
• Geriatric Medicine
• Public Health

Background:

• Radiotherapy is a common curative treatment for localized prostate cancer in elderly patients.
• Its long-term effectiveness in this population requires further evaluation.
• This study compares radiotherapy outcomes with conservative management for localized prostate cancer.

Purpose of the Study:

• To evaluate the long-term outcomes of primary radiotherapy versus conservative management for localized prostate cancer.
• To inform treatment decisions for elderly prostate cancer patients.
• To assess radiotherapy effectiveness based on disease risk stratification.

Main Methods:

• Population-based study of 57,749 patients with T1-T2 prostate cancers (1992-2007).
• Utilized an instrumental variable (IV) approach with competing risk models.
• Compared outcomes between high- and low-radiotherapy use areas.

Main Results:

• Low-/intermediate-risk prostate cancer: Similar 10-year survival (cancer-specific and overall) in high- and low-radiotherapy use areas.
• High-risk prostate cancer: Higher 10-year cancer-specific survival (90.2% vs 88.1%) and overall survival (53.3% vs 50.2%) in high-radiotherapy use areas.
• Results were robust across different IVs and radiotherapy types.

Conclusions:

• Primary radiotherapy benefits for localized prostate cancer in men >65 are primarily observed in high-risk cases (Gleason scores 7-10).
• For low- to intermediate-risk disease, radiotherapy does not significantly improve long-term survival compared to conservative management.
• Treatment decisions should consider individual risk profiles.